MIR 19
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MIR 19, covering 2022-01-11 to 2023-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19 [Phase 2, Phase 3]